A detailed history of Core Alternative Capital transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Core Alternative Capital holds 4,302 shares of TMO stock, worth $2.41 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
4,302
Previous 4,294 0.19%
Holding current value
$2.41 Million
Previous $2.5 Million 4.65%
% of portfolio
0.49%
Previous 0.45%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 16, 2024

BUY
$541.52 - $599.02 $4,332 - $4,792
8 Added 0.19%
4,302 $2.38 Million
Q1 2024

May 15, 2024

SELL
$528.82 - $599.43 $38,075 - $43,158
-72 Reduced 1.65%
4,294 $2.5 Million
Q4 2023

Feb 14, 2024

SELL
$431.41 - $532.94 $80,673 - $99,659
-187 Reduced 4.11%
4,366 $2.32 Million
Q3 2023

Oct 19, 2023

BUY
$498.29 - $574.41 $192,838 - $222,296
387 Added 9.29%
4,553 $2.3 Million
Q2 2023

Jul 27, 2023

BUY
$508.46 - $591.13 $83,895 - $97,536
165 Added 4.12%
4,166 $2.17 Million
Q1 2023

Apr 18, 2023

SELL
$535.0 - $604.82 $407,670 - $460,872
-762 Reduced 16.0%
4,001 $2.31 Million
Q4 2022

Jan 31, 2023

SELL
$484.71 - $571.37 $484 - $571
-1 Reduced 0.02%
4,763 $2.62 Million
Q3 2022

Oct 18, 2022

BUY
$507.19 - $604.49 $449,877 - $536,182
887 Added 22.88%
4,764 $2.42 Million
Q2 2022

Aug 01, 2022

BUY
$500.9 - $612.21 $682,726 - $834,442
1,363 Added 54.22%
3,877 $2.11 Million
Q1 2022

May 10, 2022

BUY
$524.0 - $644.92 $968,352 - $1.19 Million
1,848 Added 277.48%
2,514 $1.49 Million
Q4 2021

Feb 11, 2022

BUY
$569.0 - $667.24 $352,211 - $413,021
619 Added 1317.02%
666 $444,000
Q3 2021

Nov 05, 2021

BUY
$509.53 - $609.78 $23,947 - $28,659
47 New
47 $27,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $219B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Core Alternative Capital Portfolio

Follow Core Alternative Capital and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Alternative Capital, based on Form 13F filings with the SEC.

News

Stay updated on Core Alternative Capital with notifications on news.